
GSK, partner iTeos scrap development of lung cancer therapy
Audio By Carbonatix By Kamal Choudhury (Reuters) – Britain’s GSK and drug developer iTeos Therapeutics said on Tuesday they have stopped developing an experimental lung cancer drug, belrestotug, after it failed to stop the disease from progressing in two …